Advertisement

Product › Details
RADIOPHARMACEUTICAL (RPT)
![]() |
Next higher product group | cancer drug |
![]() |
Status | 1999-10-07 unspecified existent |
Record changed: 2025-01-19 |
Advertisement

More documents for RADIOPHARMACEUTICAL (RPT)
- [1] Siemens Healthineers AG. (12/10/24). "Press Release: Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging"....
- [2] Orbit Discovery Ltd.. (12/3/24). "Press Release: Orbit Discovery and Evergreen Theragnostics Expand Research Collaboration to Advance Targeted Therapeutics Development". Oxford & Springfield, NJ....
- [3] Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren....
- [4] AstraZeneca plc. (3/19/24). "Press Release: AstraZeneca to Acquire Fusion to Accelerate the Development of Next-generation Radioconjugates to Treat Cancer"....
- [5] Ariceum Therapeutics GmbH. (6/1/23). "Press Release: Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd". Berlin....
- [6] Bicycle Therapeutics plc. (5/10/23). "Press Release: Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology". Berlin, Cambridge & Boston, MA....
- [7] Mariana Oncology Inc.. (5/9/23). "Press Release: Mariana Oncology Expands Management Team, Appoints Linda Bain Chief Operating Officer and Chief Financial Officer". Cambridge, MA....
- [8] Bicycle Therapeutics plc. (5/4/23). "Press Release: Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets". Cambridge & Boston,...
- [9] Ariceum Therapeutics GmbH. (4/18/23). "Press Release: Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline". Berlin....
- [10] Bicycle Therapeutics plc. (3/28/23). "Press Release: Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates". Cambridge & Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top